Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics
Nadia Siles, Maisey Schuler, Cole Maguire, et al.
Cancers
|
January 11, 2024
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, et al.
Communications Medicine
|
May 2, 2025
SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics
Nadia Siles Alvarado, Maisey Schuler, Cole Maguire, et al.
Nature Biotechnology
|
July 17, 2018
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
Todd A Triplett, Kendra C Garrison, Nicholas Marshall, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics
Nadia Siles, Maisey Schuler, Cole Maguire, et al.
Cancers
|
January 11, 2024
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, et al.
Communications Medicine
|
May 2, 2025
SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics
Nadia Siles Alvarado, Maisey Schuler, Cole Maguire, et al.
Nature Biotechnology
|
July 17, 2018
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
Todd A Triplett, Kendra C Garrison, Nicholas Marshall, et al.
Page
of 2